Carlyle Group Inc.Carlyle Group Inc.

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings13 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ZOOMINFO TECHNOLOGIES INC

36.7M$1.1B32.1%$50.72-40.63%
11 qtrssince 2020-Q2
Decreased
0

QUIDELORTHO CORP

12.5M$1.1B31.1%$100.03-14.36%
3 qtrssince 2022-Q2
Unchanged
0

MKS INC

8.5M$718.7M20.9%$82.62-0.04%
2 qtrssince 2022-Q3
Increased
100
ONEMONEMDelisted

1LIFE HEALTHCARE INC COM

13.6M$227.5M6.6%
12 qtrssince 2020-Q1
Unchanged
0
VTRUVTRUDelisted

VITRU LTD

6.2M$140.5M4.1%
10 qtrssince 2020-Q3
Unchanged
0
GDSGDS
ADR

GDS Holdings Ltd. Sponsored ADR Class A

3.8M$77.9M2.3%$20.620.00%
1 qtr
New
80

GETTY IMAGES HOLDINGS INC

11.9M$66.1M1.9%$5.550.00%
1 qtr
New
71

SEACOR MARINE HLDGS INC

1.2M$11M0.3%$11.06-17.21%
17 qtrssince 2018-Q4
Unchanged
0
CUBECUBE
REIT

CUBESMART

220,500$8.9M0.3%$33.47+4.33%
2 qtrssince 2022-Q3
Unchanged
0
LSILSIDelisted
REIT

LIFE STORAGE INC

86,000$8.5M0.2%
2 qtrssince 2022-Q3
Unchanged
0
EMEMDelisted
ADR

SMART SH GLOBAL LTD

4.8M$5.5M0.2%$1.12-0.89%
3 qtrssince 2022-Q2
Unchanged
0

SIRIUSPOINT LTD

129,408$763,5090.0%$10.29+130.52%
8 qtrssince 2021-Q1
Unchanged
0
314,400$326,9760.0%
3 qtrssince 2022-Q2
Unchanged
0
$3.4B
AUM
13
Positions
Q4 2022
Filing
Rating · 1.5
Quarterly Portfolio Change
-17%Q3'20$7.3B+80%Q1'21$13.2B-76%Q3'22$3.1B+9%Q4'22$3.4B
Activity profile
$ moved · Q4'22
New14%Increased41%Decreased45%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q15%1-4Q46%1-2Y8%2Y+31%

Carlyle Group Inc. manages $3.4B across 13 positions as of Q4 2022. Top holdings: GTM (32.1%), QDEL (31.1%), MKSI (20.9%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q4 2022 Summary

Added 2 new positions, increased 1, trimmed 1. Top move: MKSI (INCREASED, conviction 100). Portfolio: $3.4B across 13 positions.

Top holdings by portfolio weight

Total AUM$3B
GTM32.12%
QDEL31.06%
MKSI20.91%
ONEM6.62%
VTRU4.09%
GDS2.27%
GETY1.92%
SMHI0.32%
CUBE0.26%
LSI0.25%
Other0.16%

Portfolio allocation by GICS sector

Sectors8
Technology55.30%
Healthcare31.06%
Unknown10.96%
Communication Services1.92%
Industrials0.32%
Real Estate0.26%
Consumer Cyclical0.16%
Financial Services0.02%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Healthcare, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track RecordNo data
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used